Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial…
By A. Caforio, S. Pankuweit, E. Arbustini, C. Basso, J. Gimeno-Blanes, S. Felix, M. Fu, T. Heliö, S. Heymans, R. Jahns and 14 more. European Heart Journal, 2013
3,095 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/1a6cca33d6d249d243b38a06d2181d99fd9f65cf
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors (2018, neutral): “Myocarditis was diagnosed in 2 ways: 1) standard histological features present on endomyocardial biopsy or autopsy; and 2) a guideline-recommended scoring system for clinically suspected myocarditis that incorporates several variables including the clinical, biomarker and imaging features (13).”
- 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the preventionof sudden cardiac death (2015, neutral): “In the same document, myocarditis associated with cardiac dysfunction is referred to as inflammatory cardiomyopathy, and both definitions are recommended for use by the relevant ESC recommendations.(593)”
- Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. (2018, background): “Regarding viral myocarditis, the position statement of the ESC Working Group on Myocardial and Pericardial Diseases (2013) proposed new diagnostic criteria, which are intended to reinforce the diagnosis (12).”
- Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management (2020, neutral): “myocarditis in the United States and other developed countries is viral.(9,10) Esfandiarei and McManus(8) proposed that the pathophysiology of viral myocarditis is a combination of direct cell injury and T-lymphocyte–mediated cytotoxicity, which can be augmented by the cytokine storm syndrome.”
- Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: an Expert Consensus Document (2020, background): “Maintenance of immunosuppression in case of positive PVB19 and HHV6 can depend on (1) observed initial response to immunosuppression (significant reduction of troponin or recovery of LVEF) or (2) low viral load.”
- Dilated Cardiomyopathy: Genetic Determinants and Mechanisms (2017, neutral): “EMB has been used to evaluate myocarditis and in the setting of unexplained HF.(41,42) The nonuniform nature of infiltrative disease limits the sensitivity of myocardial biopsy because the right ventricular septum is targeted for sampling.”
- EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. (2016, neutral): “infectious agents, toxins, or drugs) or internal ones like autoimmune disorders.(135,136) The incidence is difficult to ascertain since it depends on the diagnostic criteria.”